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1. Introduction
 Infectious diseases remain one of the leading causes of 
death due to antibiotic resistant microorganisms. The 
frequency of resistance in microbial pathogens continues to 
grow at an alarming rate throughout the world[1]. Decreased 
efficacy and resistance of pathogens to antibiotics has 
necessitated development of new alternatives[2]. To 
overcome these problems, the development of effective 
newer drugs without any side effects is an urgent need. 
In general, marine plants such as mangroves, seaweeds, 
sea grasses and marines sponges are extensively studied 
for antiviral, antiplasmodial, antibacterial, antifungal, 
hepatoprotective, anti ulcer properties[3,4]. But, the studies 
related to the associated microbes from marine plants are 
too limited. In view of this the present investigation was 
started to identify the antibacterial potential of seagrass 
associated microbes against bacterial pathogens.   
2. Materials and methods 
2.1. Isolation of associated microorganisms
  Fresh, young leaves and root samples of Syringodium 
isoetifolium were collected from Thondi coastal area (Lat 
9° 44’ N and Long 79° 10’ E), Tamilnadu, India, and the 
samples were surface sterilized by using 2% sodium 
hypochlorite (containing 0.1% of Tween 20) and the samples 
were rinsed 5 times with the sterile distilled water. After 
that, 1 g of each samples were aseptically weighed and 
serially diluted with 50% of seawater up to 10-6 dilutions. 
One millilitre of serially diluted sample was plated in 
various selective mediums such as starch casein agar 
(HIMEDIA) for actinomycetes, Pikovskaya’s agar (HIMEDIA) 
for phosphate solubilising bacteria, Winogradsky medium 
(HIMEDIA) for Azotobacter sp. and phophatase producing 
bacteria was isolated by using the ingredients (Peptone 3 g,
K2HPO4 0.2 g, MgSO4 0.05 g, FeCl3 0.001 g, soluble casein 
0.5 g, agar 15 g and 1 litter of 50% sea water). After that, all 
the plates were incubated at (28依3) 曟 to attain the visible 
growth of microbial cultures. The total number of bacterial 
counts was expressed as colony forming unit per mL or 
gram of sample.
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2.2. Test organisms    
  Bacterial pathogens such as antibiotic resistant pathogens 
viz., Streptococcus pneumoniae (S. pneumoniae), Klebsiella 
sp., Pseudomonas aeruginosa (P. aeruginosa), Streptococcus 
sp., and Streptococcus aureus (S. aureus) obtained from 
Vinayaka mission hospital, Salem, Tamilnadu, India, fish 
pathogens viz., Bacillus subtilis (B. subtilis), Serratia sp., 
Aeromonas hydrophila (A. hydrophila), Vibrio harveyi (V. 
harveyi) and Vibrio parahaemolyticus (V. parahaemolyticus) 
obtained from Central Institute of Fish Disease Diagnosis 
and Control, Cochin, Kerela, India.
2.3. Primary screening (Cross streak assay)
  Cross streak assay was carried out with morphologically 
different bacterial isolates against the bacterial pathogens, 
in brief, single streak of isolated strain was done on sterile 
Mueller Hinton agar plate followed by overnight culture of 
different bacterial pathogens perpendicular to the original 
streak of the isolate and incubated overnight at (37依2) 曟.
Bacterial isolate showed maximum inhibitory activity was 
selected for secondary screening[3]. 
2.4. Secondary screening
  The most potent actinomycetes strain (Act01) was selected 
for the minimum inhibitory concentration assay (MIC) and 
minimum bactericidal concentration (MBC) assays. In 
brief, the actinomycete isolate (Acto1) was mass cultivated 
by using ISP5 medium and was filtered by using Millipore 
filter. Filtrate was mixed with equal volume of ethyl 
acetate (v/v) in separating funnel and shaken well and then 
allowed to stand without any disturbance for 15 minutes. 
After that, the lower aqueous phase was discarded and 
the upper solvent phase was concentrated in a vacuum 
evaporator at room temperature for 24 h to obtain powder 
form of crude extract and stored in a refrigerator for further 
analysis. MIC assay was carried out by using 0.5 mL of 
various concentrations 512, 256, 128, 64, 32, 16 and 8 毺g/mL)
of the crude extracts were prepared with dimethyl 
sulphoxide and mixed with 50 毺L of 24 h old bacterial 
pathogens individually and incubated at 37 曟 for 48 h 
individually. To calculate the MIC, turbidity due to bacterial 
growth was observed in each concentration. To avoid the 
possibility of misinterpretations due to the turbidity of 
insoluble compounds, MBC was determined by sub culturing 
the MIC dilutions on to the sterile agar plates. The lowest 
concentration of the extracts which inhibits the growth of 
tested bacteria were observed and tabulated.
2.5. 16S rDNA amplification and sequencing
  Genomic DNA was isolated for the most potent 
actinomycetes isolate (Act01) by using standard method[5] 
and amplified by PCR with forward primer-F243 (5’-
GGATGAGCCCGCGGCCTA-3’) and reverse primer R513GC-
(5’-CGGCCGCGGCTGCTGGCACGTA-3’). The reaction 
mixture contains 25 to 50 ng of DNA, Ex Taq PCR buffer, 1.5 
mM MgCl2, 10 mM deoxynucleoside triphosphate mixture, 
50 pmol of each primer, and 0.5 U of Ex-Taq polymerase. 
PCR conditions consisted of an initial denaturation  at 94 曟 
for 5 min; 30 cycles at 94 曟 for 1min, annealing  63 曟 for 1 
min and 72  曟 for 1 min; and final 5 min extension at 72 曟.
The amplification products were examined by agarose gel 
electrophoresis and purified by using a QIA quick PCR clean 
up kit with the protocol suggested by Qiagen Inc. The partial 
16Sr DNA was sequenced by using the PCR products directly 
as sequencing template with above mentioned primers. 
All sequencing reactions were carried out with an ABI 377 
automated DNA sequencer.
2.6. Construction of phylogenetic tree
  The retrieved gene sequences were compared with other 
bacterial sequences by using NCBI BLAST search for 
their pair wise identities, further, the phylogenetic tree 
was constructed with MEGA 4.0 software (http://www.
megasoftware.net) by using the UPGMA neighbor-joining 
(NJ) method with 1 000 replicates as bootstrap value and 
NJ belongs to the distance-matrix method[5]. The 16S 
rDNA sequence was submitted to the GenBank. The RNA 
secondary structure of the isolates was predicted by using 
Genebee online software (http://www.genebee.msu.su/
services/rna2_reduced.html).
2.7. GC-MS analysis of Streptomyces sp. RAUACT-1 crude 
extract 
  About 10 mg of the most potent Streptomyces sp. crude 
extract was dissolved in 1 mL of ethyl acetate. From that,
0.1 毺Lwas injected in to GC-MS (GC 17A, Japan) with 
standard specification (column size 0.25 mm× 25 m, Carrier 
gas-Helium, Column-5% phenyl polysiloxane, flow rate
0.4 m/min, sample injection temperature 25 曟, acceleration 
and reflector temperature 10 曟/min, initial temperature 
70 曟). The maximum percentages of compounds obtained 
from the extracts were identified by chemical library search 
(TUTOR.LIB, WILEY139.LIB).
3. Results 
  The result of the present study suggested that, the 
maximum [(261.78依35.09) CFU×104/g]  counts of phosphatase 
producing bacteria  were observed in root samples. However, 
the minimum counts Actinomycetes sp. [(1.00依0.00) CFU×104/
g] was noticed in the root samples (Table 1). The results of 
the present study revealed that, the Actinomycete sp. (Act01) 
showed broad spectrum of antibacterial activity against 
all the tested pathogens and minimum level (32 毺g/mL) of MIC 
value was identified against K. pneumonia and P. aeruginosa 
bacterial pathogens. However, the maximum level (256 毺g/mL)
of MIC value was identified against B. subtilis and S. aureus. 
Further, the results of MBC were also varied between 64 毺g/mL
to 512 毺g/mL concentrations (Table 2). The results of the 
BLAST analysis showed that, the most potent Actinomycete 
sp. (Act01) showed maximum similarity indexes (99%) with 
the Streptomyces sp. and the sequence (1 514 base pairs) 
was deposited in NCBI data bank (Accession No: JN083780; 
Name: Streptomyces sp. RAUACT-1)  (Figure 1). Further, 
the results of the 16s rDNA phylogenetic analysis showed 
that, the most potent actinomycete (Act01) isolate was 
showed maximum identities (99%) with the Streptomyces sp. 
S. Ravikumar et al./Asian Pacific Journal of Tropical Medicine (2012)887-890 889
(GU5500072). The structural prediction of 16s rDNA analysis 
also carried out with the available sequences of Streptomyces 
sp. from NCBI databank (first 5 best hits from BLAST results) 
and the results showed that, the minimum (-391.4) free 
energy with the Streptomyces sp. (AM889485.1) and maximum 
free energy with the Streptomyces sp. (GU045544.1) (Figure 
2). The GC-MS result of the most potent ethyl acetate extract 
of Streptomyces sp. was showed 49 numbers of peak values 
with different time intervals, of that the maximum retention 
time value was identified 23.742RT and the chemical class 
was identified as 1, 4-dihydroxy-2-(3-hydroxybutyl)-9, 10-
anthraquinone 9, 10-anthrac (Figure 3A, 3B and 3C).     
Streptomyces sp. FJ546733.1
Streptomyces sp. DQ861639.1
Streptomyces sp. FJ546732.1
Streptomyces sp. EU080962.1
Streptomyces sp. AM889486.1
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S. deccanensis EF219459.1
Streptomyces sp. AM889485.1
Streptomyces sp. GU550072.1
   Streptomyces sp. JN083780.01 (Act01)
Streptomyces sp. HQ916737.1
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Figure 1. Phylogenetic analysis of Streptomyces sp. RAUACT-1 by 
using Niebuhr joining method with 1 000 replicates.    
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Figure 2. Secondary structure analysis of Streptomyces sp. 
RAUACT-1 with the most similar actinomycete isolates.    
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C. Identified chemical constituents [1, 4-dihydroxy-2-(3-hydroxybutyl)-9, 10-
Anthraquinone 9, 10-anthrac] present in the crude extract of Streptomyces sp. 
RAUACT-1 (MW 312).
Figure 3. GC-MS result of most potent ethyl acetate extract of 
Streptomyces sp.
Table 1
Counts of different microbial groups associated with Syringodium 
isoetifolium (CFU×104/g). 
Microbial groups
Number of counts
Root Leaf
Phosphatase producing bacteria 261.78依35.09 189.93依27.09
Phosphate solublizing bacteria 175.28依38.98 120.54依18.92
Azotobacter sp. 26.46依4.09 15.90依5.20
Actinomycetes sp.   3.00依1.00   1.00依0.00
Data represents the mean 依SD values of three replicates.
Table 2
MIC and MBC of the crude extracts obtained from Syringodium 
isoetifolium associated microbes (毺g/mL).
Pathogens
Concentration of Act01 extract
MIC MBC
Fish pathogens A. hydrophylla 128 256
B. subtilis 256 512
Serratia sp. 128 256
V. harveyi 128 128
V. parahaemolyticus 128 128
Antibiotic resistance 
pathogens
S. aureus 256 512
K. pneumonia   32   64
S. epidermis 128 128
P. aeruginosa   32   64
S. pneumonia 128 128
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4. Discussion 
  Marie environment is frequently recognized as the largest 
potential source of biodiversity and it is being increasingly 
searched for novel chemicals with useful bioactivity[6,7]. In 
view of this, the present investigation was made an attempt 
to identify the marine seagrass associated microbes for the 
possible utilization as antibacterial drugs. The results of the 
present study suggested that, the maximum counts of colony 
forming units were identified in the root samples than the 
leaf samples and this might be due to the quantity and 
quality of root derived carbon which supports the biomass 
expansion[8]. As roots grow through the soil, it releases 
photosynthetically generated carbon in to the soil in a 
variety of soluble and insoluble form, the totality of which is 
referred to as rhizodeposition[9]. Of the selected 7 different 
microbial isolates, the Actinomycetes sp. (Act01) showed 
broad spectrum of antibacterial activity against the selected 
bacterial pathogens and this might be presence of high 
content of anthraquinone compounds[10]. Similar, reports are 
also identified with other researcher findings[11-15]. Further, 
the results of the present study also suggested the MIC and 
MBC values between 128 and 512 毺g/mL concentrations. 
Ravikumar et al[2] reported the MIC and MBC values between 
the ranges of 125 to 1 000 毺g/mL concentration against 
different antibiotic resistant pathogens isolated from seagrass 
endophytes. Moreover, the results of the MBC values were 
found higher than the MIC values and this might be due 
to the endospore formation of the bacterial cells which are 
highly resistant to conditions to which vegetative cells are 
intolerant[16]. Molecular identification (16s rDNA) of the most 
potent actinomycete strain was identified as Streptomyces sp. 
In the present study the Act01 strain (JN083780) was proved 
to have potential antibacterial activities. The most nearest 
Streptomyces sp. (GU550072) from the phylogenetic tree was 
also proved to have potential antimicrobial activities from 
Xucheng soil sample (NCBI data bank-unpublished data). 
Similar reports of phylogenetic analysis was also identified 
in the marine sediment Streptomyces sp.[5]. The secondary 
structure of the most potent Actinomycete sp. (Act01) showed 
different free energy values, loop structures which might be 
due to the variations of the GC contents[17]. Hence, the lowest 
free energy values of the rDNA secondary structures provides 
the high relationship with the most primitive organisms, and 
highest free energy indicates the less stability during the 
evolutionary period[18]. It can be concluded from the present 
findings that, the actinomycete strain from the root samples 
of Syringodium isoetifolium could be used as potential 
putative source for the development of antibacterial drugs.  
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